Table 6.
Review of published studies with ≥5 patients.
| Success, n (%) | Adverse Events, n (%) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Authors | Year | DEHBD/D2 | PEHBD/D1 | LIHBD/S | DEHBD/D2 | PEHBD/D1 | LIHBD/S | ||||||||||||
| Kim et al. [9] | 2010 | 12/15 (80) | 1/15 (6.7) | ||||||||||||||||
| Dhir et al. [10] | 2012 | 57/58 (98.3) | 2/58 (3.4) | ||||||||||||||||
| Iwashita et al. [14] | 2012 | 4/9 (44.4) | 1/9 (11.1) | ||||||||||||||||
| Dhir et al. [22] | 2013 | 18/18 (100) | 16/17 (94.1) | 1/18 (5.6) | 7/17 (41.1) | ||||||||||||||
| Kawakubo et al. [7] | 2013 | 5/5 (100) | 4/4 (100) | 5/5 (100) | 1/5 (20) | 1/4 (25) | 0/5 (0) | ||||||||||||
| Park et al. [12] | 2013 | 3/6 (50) | 0/6 (0) | ||||||||||||||||
| Poincloux et al. [24] | 2015 | 5/5 (100) | 0/5 (0) | ||||||||||||||||
| Bill et al. [25] | 2016 | 19/25 (76) | 4/25 (16) | ||||||||||||||||
| Iwashita et al. [3] | 2016 | 10/10 (100) | 3/5 (60) | 3/4 (75) | 1/10 (10) | 0/5 (0) | 2/4 (50) | ||||||||||||
| Tang et al. [26] | 2016 | 20/24 (83.3) | 0/1 (0) | N/A | N/A | ||||||||||||||
| Okuno et al. [27] | 2017 | 3/4 (75) | 4/7 (57.1) | 12/16 (75) | 2/4 (50) | 1/7 (14.3) | 1/16 (6.2) | ||||||||||||
| Iwashita et al. [21] | 2018 | 14/14 (100) | 1/1 (100) | 11/13 (84.6) | N/A | N/A | N/A | ||||||||||||
| Shiomi et al. [5] | 2018 | 4/5 (80) | 6/7 (85.7) | 7/8 (87.5) | 0/5 (0) | 2/7 (28.6) | 1/8 (12.5) | ||||||||||||
| Present study | 10/10 (100) | 4/5 (80) | 1/1 (100) | 0/10 (0) | 1/5 (20) | 0/1 (0) | |||||||||||||
| Total | 58/63 (92.1) | 136/154 (88.3) | 67/85 (78.8) | 5/49 (10.2) | 12/129 (9.3) | 12/71 (16.9) | |||||||||||||
| p = 0.477 | p = 0.059 | p = 1 | p = 0.119 | ||||||||||||||||
| p = 0.038 | p = 0.426 | ||||||||||||||||||
DEHBD/D2: distal extrahepatic bile duct/duodenal second part; PEHBD/D1: proximal extrahepatic bile duct/duodenal bulb; LIHBD/S: left intrahepatic bile duct/stomach; RIHBD/D1: right intrahepatic bile duct/duodenal bulb; N/A: not applicable.